The chemokine eotaxin is unusual in that it appears to be a highly specific chemoattractant for eosinophils. Ligand-binding studies with radiolabeled eotaxin demonstrated a receptor on eosinophils distinct from the known chemokine receptors CKR-1 and -2. The distinct eotaxin binding site on human eosinophils also bound RANTES (regulated on activation T expressed and secreted) and monocyte chemotactic protein (MCP)3. We have now isolated a cDNA from eosinophils, termed CKR-3, with significant sequence similarity to other well characterized chemokine receptors. Cells transfected with CKR-3 cDNA bound radiolabeled eotaxin specifically and with high affinity, comparable to the binding affinity observed with eosinophils. This receptor also bound RANTES and MCP-3 with high affinity, but not other CC or CXC chemokines. Furthermore, receptor transfectants generated in a murine B cell lymphoma cell line migrated in transwell chemotaxis assays to eotaxin, RANTES, and MCP-3, but not to any other chemokines. A monoclonal antibody recognizing CKR-3 was used to show that eosinophils, but not other leukocyte types, expressed this receptor. This pattern of expression was confirmed by Northern blot with RNA from highly purified leukocyte subsets. The restricted expression of CKR-3 on eosinophils and the fidelity of eotaxin binding to CKR-3, provides a potential mechanism for the selective recruitment and migration of eosinophils within tissues.
Skip Nav Destination
Article navigation
1 June 1996
Article|
June 01 1996
Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils.
P D Ponath,
P D Ponath
LeukoSite, Inc., Cambridge, Massachusetts 02142, USA.
Search for other works by this author on:
S Qin,
S Qin
LeukoSite, Inc., Cambridge, Massachusetts 02142, USA.
Search for other works by this author on:
T W Post,
T W Post
LeukoSite, Inc., Cambridge, Massachusetts 02142, USA.
Search for other works by this author on:
J Wang,
J Wang
LeukoSite, Inc., Cambridge, Massachusetts 02142, USA.
Search for other works by this author on:
L Wu,
L Wu
LeukoSite, Inc., Cambridge, Massachusetts 02142, USA.
Search for other works by this author on:
N P Gerard,
N P Gerard
LeukoSite, Inc., Cambridge, Massachusetts 02142, USA.
Search for other works by this author on:
W Newman,
W Newman
LeukoSite, Inc., Cambridge, Massachusetts 02142, USA.
Search for other works by this author on:
C Gerard,
C Gerard
LeukoSite, Inc., Cambridge, Massachusetts 02142, USA.
Search for other works by this author on:
C R Mackay
C R Mackay
LeukoSite, Inc., Cambridge, Massachusetts 02142, USA.
Search for other works by this author on:
P D Ponath
LeukoSite, Inc., Cambridge, Massachusetts 02142, USA.
S Qin
LeukoSite, Inc., Cambridge, Massachusetts 02142, USA.
T W Post
LeukoSite, Inc., Cambridge, Massachusetts 02142, USA.
J Wang
LeukoSite, Inc., Cambridge, Massachusetts 02142, USA.
L Wu
LeukoSite, Inc., Cambridge, Massachusetts 02142, USA.
N P Gerard
LeukoSite, Inc., Cambridge, Massachusetts 02142, USA.
W Newman
LeukoSite, Inc., Cambridge, Massachusetts 02142, USA.
C Gerard
LeukoSite, Inc., Cambridge, Massachusetts 02142, USA.
C R Mackay
LeukoSite, Inc., Cambridge, Massachusetts 02142, USA.
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1996) 183 (6): 2437–2448.
Citation
P D Ponath, S Qin, T W Post, J Wang, L Wu, N P Gerard, W Newman, C Gerard, C R Mackay; Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils.. J Exp Med 1 June 1996; 183 (6): 2437–2448. doi: https://doi.org/10.1084/jem.183.6.2437
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement